ViaWealth’s Labcorp LH Stock Holding History

ViaWealth’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$597K	Sell	2,236 -21	-0.9%	-$5.69K	0.33%	88
2025 Q4	$566K	Sell	2,257 -161	-7%	-$42.8K	0.32%	88
2025 Q3	$694K	Sell	2,418 -125	-5%	-$33.5K	0.38%	82
2025 Q2	$668K	Sell	2,543 -137	-5%	-$33.4K	0.39%	80
2025 Q1	$624K	Hold	2,680	–	–	0.39%	81
2024 Q4	$615K	Sell	2,680 -234	-8%	-$53.7K	0.37%	84
2024 Q3	$651K	Hold	2,914	–	–	0.38%	83
2024 Q2	$593K	Buy	2,914 +3	+0.1%	+$610	0.37%	85
2024 Q1	$636K	Hold	2,911	–	–	0.4%	82
2023 Q4	$662K	Hold	2,911	–	–	0.45%	77
2023 Q3	$585K	Sell	2,911 -134	-4%	-$28.3K	0.43%	78
2023 Q2	$631K	Buy	3,045 +17	+0.6%	+$3.3K	0.47%	69
2023 Q1	$597K	Hold	3,028	–	–	0.47%	74
2022 Q4	$633K	Buy	+3,028	New	+$592K	0.52%	67

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ViaWealth's LH Position: Q1 2026 in Review

ViaWealth reduced its Labcorp (LH) stake by 0.93% in Q1 2026, selling an estimated $5.69K and leaving 2,236 shares worth $597K. The position accounts for 0.33% of the portfolio, ranked #88.

ViaWealth first reported a position in LH in Q4 2022 and has held it in 14 quarters since. The position peaked at $694K in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

ViaWealth held 2,236 shares of Labcorp worth $597K as of Q1 2026.
ViaWealth sold 21 Labcorp shares in Q1 2026, an estimated $5.69K.
Labcorp made up 0.33% of ViaWealth's portfolio in Q1 2026, its #88 holding.
ViaWealth first reported a position in Labcorp in Q4 2022 and has held it in 14 quarters since.
ViaWealth's Labcorp position peaked at $694K in Q3 2025.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on ViaWealth's 13F filing for Q1 2026, filed 11 May 2026.